Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Topics : Blood and lymphatic diseases
  • Topics : Hematologic cancers
  • Topics : Lymphatic diseases
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Transfusions, transplantations (1)
    • Drug therapy (1)
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
  • Diseases and conditions (2)
  • Plus ...
    • Blood and lymphatic diseases (2)
    • Plus ...
      • Lymphatic diseases (2)
      • Hematologic cancers (2)
    • Infectious diseases (1)
    • Plus ...
      • Virus diseases (1)
    • Skin and connective tissue diseases (1)
    • Plus ...
      • Skin and connective tissue cancers (1)
    • Immune system diseases (1)
    • Plus ...
      • Immune system diseases - miscellaneous (1)
Content type
  • Drugs, devices and medical acts (2)
  • Plus ...
    • Medicine (1)
    • Health technology assessment (1)
Language
  • Français (2)
Active substance
  • dacarbazine (1)
  • ganciclovir (1)
  • rituximab (1)
 More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 2 results

  • DACARBAZINE MEDAC (dacarbazine)

    Medicine - Posted on 30/11/2018 - Mis à jour le 12/6/2019
    Add to my selection

  • Laboratory examinations to test for Epstein-Barr virus as part of post-transplant lymphoproliferative disorder

    Health technology assessment - Posted on 20/11/2015
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
2zRaL7MeSY6enewW